Inventor · disambiguated record
David Jonaitis
Also filed as: JONAITIS DAVID · JONAITIS DAVID T · JONAITIS DAVID THOMAS
35 granted patents·14 pending applications·159 citations·filing 2003–2025
96Inventor score
Top patents by PatentIndex Score
49 records- 0196US9695146B2Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereofCELGENE CORP·Filed 2014·Granted Jul 4, 2017·17 cites·43 claims
- 0296US8088824B2Forms of CDDO methyl esterWALLING JOHN·Filed 2008·Granted Jan 3, 2012·54 cites·16 claims
- 0395US8309601B2Forms of CDDO methyl esterWALLING JOHN·Filed 2011·Granted Nov 13, 2012·40 cites·9 claims
- 0492US11827600B2Crystalline forms of trofinetideACADIA PHARM INC·Filed 2022·Granted Nov 28, 2023·3 cites·19 claims
- 0592US8633243B2Forms of CDDO methyl esterWALLING JOHN·Filed 2012·Granted Jan 21, 2014·18 cites·1 claims
- 0691US11478447B2Solid Δ9-tetrahydrocannabinol (Δ9-THC) compositionsCANNA CHEMISTRIES LLC·Filed 2022·Granted Oct 25, 2022·1 cites·2 claims
- 0791US10376503B2Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereofCELGENE CORP·Filed 2018·Granted Aug 13, 2019·2 cites·38 claims
- 0888US9974780B2Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereofCELGENE CORP·Filed 2017·Granted May 22, 2018·2 cites·38 claims
- 0984US10765693B2Polymorphic compounds and uses thereofASTROCYTE PHARMACEUTICALS INC·Filed 2019·Granted Sep 8, 2020·3 cites·13 claims
- 1083US12295962B2Polymorphic compounds and uses thereofASKAT INC·Filed 2024·Granted May 13, 2025·0 cites·12 claims
- 1183US11324769B2Polymorphic compounds and uses thereofASTROCYTE PHARMACEUTICALS INC·Filed 2020·Granted May 10, 2022·2 cites·40 claims
- 1282US9968627B2Solid forms comprising 4-amino-1-β-D-ribofuranosyl-1,3,5-triazin-2(1H)-one and a coformer, compositions and methods of use thereofCELGENE CORP·Filed 2014·Granted May 15, 2018·2 cites·21 claims
- 1381US2024408049A1Solid delta9-tetrahydrocannabinol (delta9-thc) compositionsCANNA CHEMISTRIES LLC·Filed 2024·Application pending·0 cites
- 1479US9808450B2Solid forms comprising 3-(4-amino-1-OXO-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and a coformer, compositions and methods of use thereofCELGENE CORP·Filed 2014·Granted Nov 7, 2017·1 cites·38 claims
- 1579US7605270B2Polymorphic forms of (S).-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamateVERTEX PHARMA·Filed 2006·Granted Oct 20, 2009·3 cites·10 claims
- 1678US12090137B2Solid Δ9-tetrahydrocannabinol (Δ9-THC) compositionsCANNA CHEMISTRIES LLC·Filed 2022·Granted Sep 17, 2024·0 cites·14 claims
- 1778US7858594B2Crystalline and amorphous forms of beta-L-2′-deoxythymidineNOVARTIS PHARMA AG·Filed 2009·Granted Dec 28, 2010·0 cites·15 claims
- 1876US12358874B2Crystalline salts of psilocinCANNA CHEMISTRIES LLC·Filed 2024·Granted Jul 15, 2025·0 cites·20 claims
- 1976US7589079B2Crystalline and amorphous forms of beta-L-2′-deoxythymidineNOVARTIS AG·Filed 2007·Granted Sep 15, 2009·1 cites·35 claims
- 2075US8003700B2Colchicine solid complex; methods of making; and methods of use thereofMUTUAL PHARAMACEUTICAL COMPANY INC·Filed 2009·Granted Aug 23, 2011·4 cites·7 claims
- 2174US9101642B2Ticagrelor co-crystalCOSGROVE STEPHEN DAVID·Filed 2012·Granted Aug 11, 2015·2 cites·17 claims
- 2273US12492167B2Crystalline forms of trofinetideACADIA PHARM INC·Filed 2023·Granted Dec 9, 2025·0 cites·39 claims
- 2373US11406629B2Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereofCELGENE CORP·Filed 2020·Granted Aug 9, 2022·0 cites·27 claims
- 2472US2022016072A1Solid delta9-tetrahydrocannabinol (delta9-thc) compositionsCANNA CHEMISTRIES LLC·Filed 2021·Application pending·0 cites
- 2571US11970447B2Crystalline salts of psilocinCANNA CHEMISTRIES LLC·Filed 2022·Granted Apr 30, 2024·0 cites·18 claims
- 2671US10835522B2Solid forms comprising 4-amino-2-(2,6- dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereofCELGENE CORP·Filed 2019·Granted Nov 17, 2020·0 cites·38 claims
- 2768US7323451B2Crystalline and amorphous forms of beta-L-2′-deoxythymidineIDENIX PHARMACEUTICALS INC·Filed 2003·Granted Jan 29, 2008·1 cites·15 claims
- 2866US9149539B1Crystalline naloxol-PEG conjugateASTRAZENECA AB·Filed 2015·Granted Oct 6, 2015·1 cites·1 claims
- 2965US9012469B2Crystalline naloxol-peg conjugateÅSLUND BENGT LEONARD·Filed 2011·Granted Apr 21, 2015·2 cites·14 claims
- 3061US2024327426A1Crystalline forms of ceftibutenQPEX BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 3161US2025368668A1Crystalline forms and salt forms of a cardiac p2x receptor agonist, pharmaceutical compositions, and their use in treating medical disordersCORNOVUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3259US7989632B2Crystalline forms of solvated ilaprazoleIL YANG PHARMACEUTICAL COMPANY LTD·Filed 2007·Granted Aug 2, 2011·0 cites·2 claims
- 3359US2021315909A1Polymorphic compounds and uses thereofARRYS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3459US2024300882A1Crystalline forms of a diffusion enhancing compoundDIFFUSION PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 3558US11866420B2Hydrochloride salt forms of a sulfonamide structured kinase inhibitorAURIGENE ONCOLOGY LTD·Filed 2019·Granted Jan 9, 2024·0 cites·14 claims
- 3658US8153668B2Polymorphic forms of (S)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzylcarbamateBLYTHE TODD·Filed 2009·Granted Apr 10, 2012·0 cites·4 claims
- 3758US7999110B2Solid state forms of racemic ilaprazoleIL YANG PHARMACEUTICAL COMPANY LTD·Filed 2007·Granted Aug 16, 2011·0 cites·3 claims
- 3857US2018000808A1Solid forms comprising 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and a coformer, compositions and methods of use thereofCELGENE CORP·Filed 2017·Application pending·0 cites
- 3956US8519002B2Colchicine solid complex; methods of making; and methods of use thereofSUN TONG·Filed 2011·Granted Aug 27, 2013·0 cites·18 claims
- 4054US2007149457A1Stable solid forms of enterostatinRUBIN BYRON·Filed 2006·Application pending·0 cites
- 4150US8592600B2Solid state forms of racemic ilaprazoleBRACKETT JOHN M·Filed 2010·Granted Nov 26, 2013·0 cites·3 claims
- 4250US8592599B2Solid state forms of racemic ilaprazoleBRACKETT JOHN M·Filed 2010·Granted Nov 26, 2013·0 cites·3 claims
- 4349US2022117912A1L-pipecolic acid cocrystal of cannabidiolEBERS TECH INC·Filed 2020·Application pending·0 cites
- 4449US2008200515A1Solid state forms of enantiopure ilaprazoleTAP PHARMACEUTICAL PROD INC·Filed 2007·Application pending·0 cites
- 4546US2016176912A1Novel Ticagrelor Co-CrystalASTRAZENECA AB·Filed 2015·Application pending·0 cites
- 4646US2010069389A1Novel forms of reboxetineBIONEVIA PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4741US7863276B2Salts of modulators of PPAR and methods of treating metabolic disordersKALYPSYS INC·Filed 2006·Granted Jan 4, 2011·0 cites·9 claims
- 4841US2007299136A1Crystalline and Amorphous Forms of Efaproxiral SodiumALLOS THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 4939US2008070961A1Polymorphs of N-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)-amino]sulfonyl}-2-thiophene-carboxamideREICHWEIN JOHN F·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Jonaitis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →